Reply to Alffenaar et al

Clin Infect Dis. 2017 Jan 1;64(1):105-106. doi: 10.1093/cid/ciw679. Epub 2016 Oct 26.

Authors

Charles A Peloquin¹, Susan E Dorman², Andrew Vernon³, Giovanni Battista Migliori⁴, Payam Nahid⁵

Affiliations

¹ University of Florida, Gainesville.
² Johns Hopkins University, Baltimore, Maryland.
³ Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁴ World Health Organization Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri Care and Research Institute, Tradate, Italy.
⁵ University of California, San Francisco.

PMID: 27789610
DOI: 10.1093/cid/ciw679

No abstract available

Publication types

Letter
Comment

MeSH terms

Centers for Disease Control and Prevention, U.S.
Communicable Diseases*
Disease Susceptibility
Humans
Tuberculosis*
United States